HIV vaccine development in the aftermath of the STEP study: re-focus on occult HIV infection?

HIV vaccine development in the aftermath of the STEP study: re-focus on occult HIV infection?

Bibliographic Details
Main Author:	Klaus Uberla
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2008-01-01
Series:	PLoS Pathogens
Online Access:	http://europepmc.org/articles/PMC2517652?pdf=render

Similar Items

Developing an HIV vaccine: the role of efficacy studies in nonhuman primates.
by: Klaus Uberla
Published: (2005-04-01)

The aftermath of the Merck's HIV vaccine trial
by: Quinto Ileana, et al.
Published: (2008-07-01)

Characterization of Occult Hepatitis B Virus Infection in HIV-Positive Individuals
by: Martin Quigley, Christina M.
Published: (2011)

Occult Hepatitis B in HIV Positive Batswana
by: Ryan, Kathleen T., M.D.
Published: (2016)

Overt and occult hepatitis B virus infection in adult Sudanese HIV patients
by: Hatim Mudawi, et al.
Published: (2014-12-01)

Occult Hepatitis B Virus Infection among HIV Positive Patients in Nigeria
by: Oluyinka Oladele Opaleye, et al.
Published: (2014-01-01)

Occult Hepatitis B Virus Infection in Egyptian HIV-Infected Patients with Isolated Anti-HBc
by: Naglaa F. Abdelaziz, et al.
Published: (2019-12-01)

HPV vaccination in HIV infection
by: Charles JN. Lacey
Published: (2019-12-01)

Bringing the path toward an HIV-1 vaccine into focus.
by: Cesar J Lopez Angel, et al.
Published: (2020-09-01)

Influenza vaccination in HIV-infected patients
by: Michał Jędrychowski, et al.
Published: (2019-03-01)

BCG Vaccination in HIV-Infected Children
by: James J. C. Nuttall, et al.
Published: (2011-01-01)

HIV-1 Vaccine Development: Enlightened by Single Infection or Sequential Infections?
by: Jianqing Xu
Published: (2016-07-01)

The Need for Development of New HIV-1 Reverse Transcriptase and Integrase Inhibitors in the Aftermath of Antiviral Drug Resistance
by: Mark A. Wainberg
Published: (2012-01-01)

Glycosylation of HIV Env Impacts IgG Subtype Responses to Vaccination
by: Rebecca Heß, et al.
Published: (2019-02-01)

Effect of HIV Envelope Vaccination on the Subsequent Antibody Response to HIV Infection
by: Zanele Ditse, et al.
Published: (2020-01-01)

HIV-1 vaccine development
by: LeÌtourneau, Sven C.
Published: (2006)

Hepatitis B infection among HIV infected individuals in Gabon: Occult hepatitis B enhances HBV DNA prevalence.
by: Berthold Bivigou-Mboumba, et al.
Published: (2018-01-01)

Occult hepatitis B virus infection in a Kenyan cohort of HIV infected anti-retroviral therapy naïve adults.
by: Adil Salyani, et al.
Published: (2021-01-01)

Occult HBV infection among anti-HBc positive HIV-infected patients in apex referral centre, Eastern India
by: R. Panigrahi, et al.
Published: (2012-11-01)

Pneumococcal vaccination for HIV-infected individuals in Singapore
by: Paul V Licciardi, et al.
Published: (2019-03-01)

Pneumococcal Vaccination in Aging HIV-Infected Individuals
by: Ohtola, Jennifer A.
Published: (2015)

Viral Factors Associated with Occult HBV in HIV-positive South Africans
by: Powell, Eleanor A.
Published: (2015)

No evidence for occult HBV infection in hepatitis B vaccine non-responders
by: Mohammad Reza Aghasadeghi, et al.
Published: (2014-10-01)

Re-framing salmon aquaculture in the aftermath of the ISAV crisis in Chile
by: Bachmann-Vargas, P., et al.
Published: (2021)

First report of occult hepatitis B infection among ART naïve HIV seropositive individuals in Maputo, Mozambique.
by: Awa Abdul Carimo, et al.
Published: (2018-01-01)

Occult hepatitis B virus infection in HIV positive patients at a tertiary healthcare unit in eastern India.
by: Debraj Saha, et al.
Published: (2017-01-01)

Prevalence of Occult Hepatitis B Virus Infection in a Cohort of HIV-Positive Patients Resident in Sicily, Italy
by: Fabio Tramuto, et al.
Published: (2013-01-01)

Distinct susceptibility of HIV vaccine vector-induced CD4 T cells to HIV infection.
by: Sarah Auclair, et al.
Published: (2018-02-01)

Advances in HIV-1 Vaccine Development
by: Yong Gao, et al.
Published: (2018-04-01)

More surprises in the development of an HIV vaccine
by: Jose eEsparza, et al.
Published: (2014-07-01)

DNA Immunization for HIV Vaccine Development
by: Yuxin Chen, et al.
Published: (2014-02-01)

A Strategy for Developing an HIV Vaccine
Published: (2005-01-01)

Afghanistan 'Gozargah' : discourses on gender-focused aid in the aftermath of conflict
by: Abirafeh, Lina
Published: (2008)

Plasticity of HIV-specific CD8 T cell responses in untreated HIV-1 infection- a step towards a therapeutic vaccine against drug resistance mutations
by: Roider J, et al.
Published: (2012-09-01)

Hermeneutic re-definition, re-occulting H.D.'s Trilogy
by: Gallant-Robinson, Matthew
Published: (2006)

Mycobacterium tuberculosis infection interferes with HIV vaccination in mice.
by: Lech Ignatowicz, et al.
Published: (2012-01-01)

Response to Hepatitis B Vaccine in HIV-Infected Patients
by: SH Afrasiabian, et al.
Published: (2007-07-01)

Antibody-Dependent Cellular Cytotoxicity and NK Cell-Driven Immune Escape in HIV Infection: Implications for HIV Vaccine Development
by: Gamze Isitman, et al.
Published: (2012-01-01)

HIV-1 Infections During Vaccine Trials: Identifying New Peptides for Differential Diagnosis of HIV-1 Infections in the Face of Vaccine-generated Antibodies
by: Golding Hana, et al.
Published: (2005-12-01)

HIV-1 Infections During Vaccine Trials: Identifying New Epitopes For Differential Diagnosis Of HIV-1 Infections In The Face Of Vaccine -Induced Antibodies
by: Khurana Surender, et al.
Published: (2005-12-01)

Cannot write session to /tmp/vufind_sessions/sess_qlvchel12rjj6o44g3nva2ni41